Dopamine (DA) is a neurotransmitter with conserved behavioral roles between invertebrate and vertebrate animals. In addition to its neural functions, in insects DA is a critical substrate for cuticle pigmentation and hardening. Drosophila tyrosine hydroxylase (DTH) is the rate limiting enzyme for DA biosynthesis. Viable brain DA-deficient flies were previously generated using tissue-selective GAL4-UAS binary expression rescue of a DTH null mutation and these flies show specific behavioral impairments. To circumvent the limitations of rescue via binary expression, here we achieve rescue utilizing genomically integrated mutant DTH. As expected, our DA-deficient flies have no detectable DTH or DA in the brain, and show reduced locomotor activity. This deficit can be rescued by L-DOPA/carbidopa feeding, similar to human Parkinson's disease treatment. Genetic rescue via GAL4/UAS-DTH was also successful, although this required the generation of a new UAS-DTH1 transgene devoid of most untranslated regions, as existing UAS-DTH transgenes express in the brain without a Gal4 driver via endogenous regulatory elements. A surprising finding of our newly constructed UAS-DTH1m is that it expresses DTH at an undetectable level when regulated by dopaminergic GAL4 drivers even when fully rescuing DA, indicating that DTH immunostaining is not necessarily a valid marker for DA expression. This finding necessitated optimizing DA immunohistochemistry, showing details of DA innervation to the mushroom body and the central complex. When DA rescue is limited to specific DA neurons, DA does not diffuse beyond the DTH-expressing terminals, such that DA signaling can be limited to very specific brain regions.
Received 07 July 2016 , revised 21 September 2016 and 17 October 2016 , accepted for publication 17 October 2016 Dopamine (DA) is a conserved neurotransmitter responsible for controlling voluntary movement (Riemensperger et al. 2011 ), arousal (Friggi-Grelin et al. 2003a Lebestky et al. 2009 ), sleep (Nall et al. 2016; Ueno et al. 2012) , male courtship behaviors (Liu et al. 2008) , learning and reward in Drosophila (Owald & Waddell 2015; Swinderen & Andretic 2011) and vertebrates (reviewed in Iversen & Iversen 2007) . Its importance for humans is manifested in pathological conditions such as Parkinson's disease (PD), caused by death of DA neurons via only partly understood mechanisms (Brichta & Greengard 2014; Kalia & Lang 2015) .
A variety of PD models have been developed in Drosophila and mice, all of which lead to age-dependent loss of variable fractions of DA neurons (Coulom & Birman 2004; Feany & Bender 2000; Meredith & Rademacher 2011; Tieu 2011 ). In addition, models have been developed in mouse and Drosophila in which the rate limiting tyrosine hydroxylase (TH) enzyme for DA biosynthesis is directly targeted, to better separate the effects of DA loss from factors involved with loss of the DA neurons (Darvas & Palmiter 2009; Henschen et al. 2013; Hnasko et al. 2006; Riemensperger et al. 2011; Zhou & Palmiter 1995) .
The DA is critical for cuticle sclerotization and melanization in insects (Andersen 2010; Brunet 1980; Wright 1987) . Loss of the Drosophila tyrosine hydroxylase gene (DTH, encoded by the ple gene) results in embryonic lethality (Neckameyer & White 1993) . Viable lines of brain DA-deficient fruit flies were first generated by Riemensperger et al. 2011, utilizing tissue-specific rescue of the DTH null allele ple 2 in the hypoderm, but not in the central nervous system (CNS). This was accomplished by taking advantage of the DTH tissue-specific alternative splicing mechanism, which results in DTH mRNA and protein isoforms that differ between the CNS and hypoderm (Birman et al. 1994; Friggi-Grelin et al. 2003a) . Two compensating frameshift (FS +/− ) point mutations in the DTH gene (DTH FS+/− ) disrupt the translation of the CNS-specific isoform, but preserve the expression of the hypodermal isoform. A UAS-DTH FS+/− transgene expressed under the combined control of TH-Gal4 and DDC-Gal4 fully rescue the lethality of DTH null allele ple 2 , without any detectable DA in the adult brain (Riemensperger et al. 2011) .
Though the approach of Riemensperger et al. (2011) was successful, there are two limitations. First, both TH-Gal4 and DDC-Gal4 drivers are required to achieve hypodermal DA rescue, leading to ectopic expression of TH in DDC-GAL4 expressing serotonin neurons. Second, this initial approach uses the GAL4-UAS binary expression system, greatly complicating further studies requiring additional transgenes, for example, studying the functions of specific DA neurons by restoring DA to selected neuronal subsets. We addressed both these limitations by rescuing ple 2 with a 20 kb genomic DTH FS+/− bacterial artificial chromosome (BAC), utilizing endogenous DTH regulatory elements. This strategy eliminates ectopic TH expression in serotonergic neurons and facilitates further genetic manipulations by simplifying the DA-deficient genetic background. Our new DA deficiency model shows locomotor deficits similar to those observed in the previous approach of Riemensperger et al. (2011) . We further show that the human Parkinson's treatment of L-DOPA (L-3,4-dihydroxyphenylalanine) plus carbidopa works efficiently in Drosophila, indicating mechanistic conservation between the fly model with humans as to passage of biogenic amines through the blood-brain barrier. In addition to enabling future behavioral studies, our approach to establish genetic rescue of neural DA in this new background has uncovered several interesting facets of DTH gene, DTH protein post-translational regulation and DA neuronal localization that have broad implications for studies of catecholamine functions in other systems.
Results

Generation of DA-deficient Drosophila
We used homologous recombination in bacteria to introduce the aforementioned DTH FS+/− mutations into a 20 kb DTH BAC (Fig. S1 , Supporting Information) (Venken et al. 2006 (Venken et al. , 2009 . After integrating this transgene into the third chromosome docking site attP2, the ple 2 mutation was genetically recombined into this strain, with recombinants detected by sequencing (Fig. S2) . In parallel, a wild-type rescue control strain was generated that contained the parent 20 kb DTH BAC in the ple 2 background (DTH ple 2 ). Immunohistochemistry confirmed that DTH is not detectable in brains from DTH FS+/− ple 2 (hereafter referred to as 'DA-deficient') flies, whereas DTH ple 2 flies show the normal pattern of TH-immunoreactive (TH IR) neurons (Figs. 1a,2b ). As expected, DA-deficient flies have no detectable DA in brain extracts as assayed by high performance liquid chromatography (HPLC) (Hardie & Hirsh 2006) (Fig. 1b) .
Individual DA neurons innervate distinct subregions of the mushroom body (MB) and the central complex (CC), regions involved in learning and memory (Mao et al. 2009; Pech et al. 2013) and regulating locomotion and sleep/wake (Kong et al. 2010; Liu et al. 2012) , respectively. In course of this study, we optimized DA immunohistochemistry (Budnik & White 1988; Riemensperger et al. 2011) , which allowed us to directly visualize DA innervation in these release sites (Figs. 1a,2a , Videos S1-S3), as well as in DA cell bodies, with a distinct pattern similar to DTH immunohistochemistry (Fig. 2a,b , Video S1, Table S1 ). However, DA IR shows vastly enhanced levels at DA terminals in MB and CC relative to DTH IR.
DA-deficient flies have reduced locomotor activity, and respond to L-DOPA/carbidopa treatment
The DA-deficient flies show the expected phenotype of spontaneous locomotor hypoactivity (Fig. 3b) (Riemensperger et al. 2011) . To determine whether these hypoactive flies might retain functional levels of DA, we fed them 3-iodotyrosine (3-IY), a DTH inhibitor that when fed to wild-type flies leads to a significant decrease in locomotor activity (Neckameyer 1996; Riemensperger et al. 2011) . As shown in Fig. 3a ,b, the DTH ple 2 flies are sensitive to 3-IY feeding, but the DA-deficient flies are insensitive, indicating that the remaining activity in these flies is not dependent on trace levels of DTH activity.
We next attempted pharmacological rescue of the low locomotor activity phenotype in the DA-deficient flies. Including the DA precursor L-DOPA in the food resulted in no significant increase in locomotor activity and only a partial rescue of DA (Fig. 3a,c) . This differs from findings of (Riemensperger et al. 2011) , but that study examined different behaviors and selected explicitly for flies consuming the food. The efficacy of oral L-DOPA therapy in human Parkinson's patients is increased by simultaneous dosing with carbidopa, a DOPA decarboxylase (DDC) inhibitor (Neha Singh 2007) . Carbidopa functions by preventing L-DOPA conversion to DA in the periphery, thus allowing more L-DOPA to cross the blood-brain barrier (BBB) (Seeberger & Hauser 2007) . To determine whether a similar mechanism might hold in Drosophila, we added increasing concentrations of carbidopa to the L-DOPA containing food. As shown in Fig. 3c , the lowest concentration of carbidopa, 0.0125 mg/ml, results in complete rescue of locomotor activity and brain DA levels (Fig. 3d) , with increasing doses of carbidopa resulting in supra-normal DA levels, with a concomitant graded increase in locomotor activity. However, all combinations of L-DOPA/carbidopa resulted in locomotor activity levels significantly greater than wild type (Fig. 3c ). These observations suggest that the Drosophila BBB functions similarly to that in higher animals, with permeability to L-DOPA but not to DA. Lack of BBB permeability to physiological levels of DA is indicated by the finding that adult flies contain significant levels of DA in the hemolymph (Zhao et al. 2010) . If the BBB were permeable to DA, it would not be possible to generate flies lacking brain DA.
Undriven UAS-DTH constructs restore DA biosynthesis
A major motivation for constructing this DA-deficient background was to allow neuron-selective rescue of DA synthesis using GAL4 lines that drive UAS-DTH expression in specific subsets of DA neurons. In the course of initiating these studies, we performed the routine control of examining brain DA of UAS-DTHg transgene (Fig. 4a ) in the absence of a GAL4 driver in the DA-deficient background. We found a most unexpected result, namely that the undriven UAS-DTHg (Friggi-Grelin et al. 2003b; Riemensperger et al. 2011) expresses normal DA levels, as assessed by HPLC (Fig. 4b) . The most likely explanation for this result is that neuronal expression of DTHg is driven via intra-genic transcriptional regulatory elements, a result consistent with the location of elements required for neuronal DTH expression (Friggi-Grelin et al. 2003a; Liu et al. 2012) . Other available UAS-DTH constructs also showed partial DA rescue. The UAS-DTH1 (Friggi-Grelin et al. 2003b ) removes most DTH introns, retaining only introns 3 and 4, yet this undriven construct still rescues DA to ∼50% of normal levels (Fig. 4b ). brains show near-normal levels of DA, whereas DA-deficient brains show <5% normal levels of DA, with the residual peak most likely caused by an unknown electroactive compound that can comigrate with DA (Riemensperger et al. 2011) [***P < 1E-10, *P < 0.01, one-way ANOVA (Bonferronicorrected), error bars represent SEM, n = 6-10].
Undriven UAS-DTH2 (True et al. 1999 ) also rescued significant amounts of DA (Fig. 4b) .
To address this issue, we generated constructs containing even less non-coding DTH sequences. A minimal construct, DTH1m, that removes almost all DTH non-coding sequences, retaining only 12 bp of 5 ′ untranslated regions (UTR) containing the Kozak sequence (Fig. 4a) , yielded the desired result, in that it fails to rescue any detectable DA in the DA-deficient background in the absence of a GAL4 driver (Fig. 4b) . The TH-Gal4 and/or DDC-Gal4;UAS-DTH1m mediated rescue in the DA-deficient background restores normal locomotion (Fig. 4c) , 50-60% normal DA level measured by HPLC (Fig. 4d ) and brain DA immunohistochemistry (Fig. 4e) .
Surprisingly, DTH immunoreactivity is drastically decreased in flies in which UAS-DTH1m is driven by the single or combined action of TH-Gal4 and DDC-Gal4 (Figs. 4f,S3 ), even though this transgene is capable of rescuing significant DA levels in the DA-deficient background (Fig. 4d,e) . Images of the posterior DA-neurons of TH-GAL4/DDC-Gal4:DTH1m rescued brains show very faint TH IR in cell bodies (Fig. S3 ).
Because the DTH protein is subject to feedback inhibition by DA (Vié et al. 1999) , low-level expression of DTH1 in a DA-deficient neuron should result in a highly active/phosphorylated DTH1 protein that would remain fully active until intracellular DA levels approach normal. We tested if DTH phosphorylation, potentially modifying the epitope recognized by the antibody, could be responsible for the lack of TH IR in TH-GAL4/DDC-Gal4:DTH1m rescued flies, by increasing brain DA levels with L-DOPA/carbidopa feeding (Fig. S3) . We found no effect of this treatment on TH IR. Because mRNA expression levels of the neural DTH1 isoform are normal in this genotype (Fig. S4 ) the most likely explanation for the low TH IR expressed from UAS-DTH1m is poor translatability of the mRNA caused by severe pruning of the untranslated regions.
The low level of DTH1 expression detected by our TH IR protocol indicates a potential discordance between TH IR and the presence of DA, providing the initial rationale to optimize detection of DA IR. Budnik and White (1988) ) detected DA in cell bodies in whole mount larval CNS preparations of Drosophila. Riemensperger et al. (2011) adapted this procedure to whole mount adult brain, but signal to noise was low, with little to no DA IR detected in DA neuron terminals. With our optimized protocol (see Methods) we have been able to achieve high signal to noise with extensive DA IR observed in terminals and essentially no signal remaining in the adult brains of the DA-deficient flies (Fig. 1a , Videos S1-S3).
DA biosynthesis can be strictly limited to selected mushroom body subdomains
We used the split-Gal4 expression system (Luan et al. 2006; Pfeiffer et al. 2010) with UAS-DTH1m to rescue DA in small subsets of DA neurons. Activation domain (AD) drivers overlapping with subsets of DA neurons were combined with TH-DBD and DDC-DBD Gal4 drivers (Aso et al. 2014b) (Figs. 5,S5, Table 1 ). In a separate experiment, these driver combinations were used to drive mCD8-GFP expression in a wild-type DA background, which allowed mapping of DA neurons relative to TH IR (Figs. 5,S5) .
The neurons detected in this experiment by DA IR innervate subregions of the MB (Fig. 5) , showing high spatial specificity. Furthermore, there is no detectable diffusion of DA that would lead to DAT-dependent reuptake to projections from nearby neurons. Of particular interest are the split R58E02 and R76F05 GAL4 driver combinations that target subsets of the PAM neurons, comprising ∼110 small medially localized cell bodies. The R58E02/TH split GAL4 drivers target ∼10 of these neurons, whereas the R58E02/DDC drivers target ∼75. The former targets PAM DA neurons at the medial tip of the horizontal lobes, apparently the 2 2 ′ 5 domain, whereas the latter targets the entirety of the horizontal lobes. This subset of PAM neuron cell bodies appears to be highly intermingled and in rather close proximity to other PAM neurons (Aso et al. 2014b) . Because this cluster of ∼110 PAM neuron cell bodies is roughly 40 μm in diameter, we consider it unlikely that somatic release/reuptake of DA is occurring (Rice & Patel 2015) within the PAM neuronal cluster.
Discussion
We developed a Drosophila strain that lacks DA in the brain. This new model reproduces hypoactivity phenotypes of the previous model Riemensperger et al. 2011) , which resemble those observed with pharmacological DTH inhibition using 3-IY. A combination of drugs used in PD treatment was able to rescue this behavioral hypoactivity. In Riemensperger et al. (2011) , L-DOPA feeding alone was able to rescue negative geotaxis behavior. However, the two studies use different feeding protocols and behavioral assays, making comparisons difficult.
We were able to restore DA biosynthesis in selected neurons using a new UAS-DTH1 construct that lacked regulatory elements contained in previously constructed UAS-DTH transgenes, which allowed DTH expression even in the absence of a GAL4 driver. The UAS-DTH1m transgene we developed shows no basal expression, allows full rescue of DA and locomotor activity. Paradoxically, the TH gene product from UAS-DTH1m is almost undetectable by TH IR. The simplest explanation for this unexpected finding is that this transgene must be translated at a very low level due to severe pruning of 5 ′ and 3 ′ UTR. Because the DTH1 protein encoded by this construct is subject to regulation by feedback inhibition by DA (Vié et al. 1999) , expression of low levels of DTH1 protein in a DA depleted neuronal environment would result in a phosphorylated protein with high TH activity, allowing efficient restoration of normal DA levels. This discordance between DA vs. TH IR is of broad interest given the common use of TH IR as a catecholaminergic marker in vertebrate neuronal systems where TH is similarly regulated (Vié et al. 1999) . The DA does not diffuse nor is recycled in distant neurons and its biosynthesis and signaling can be limited to specific MB neurons. Patterns of split-Gal4 DA neuron subsets mapped with UAS-GFP (green) on a DTH/DA-competent background coimmunostained for TH (red); maximum intensity projections of whole brain. DA-rescue in subsets of DA-neurons using Split-Gal4 system on a DA-deficient background show innervation limited to specific MB neurons; DA immunohistochemistry (grey); maximum intensity projections of MB planes. Even though the Split-Gal4 expression system is highly specific, we found some off-target neurons expressing UAS-GFP that do not overlap with TH IR and do not show DA IR in rescued brains (figure). We also noticed a surprising coverage of the PPL1 DA neurons by the DDC-DBD driver (Table 1) , which was absent from the DDC-Gal4 pattern (Aso et al. 2012) .
Roles for specific subsets of DA neurons and their respective MB innervation regions in learning and memory (reviewed in Aso et al. 2014a; Waddell 2013 Waddell , 2016 ) and locomotion control (Agrawal & Hasan 2015; Kong et al. 2010; Riemensperger et al. 2013 ) have been determined using conditionally regulated silencing and activating genes, and by utilizing live Ca 2+ imaging. In particular, these studies show that subsets of PAM neurons and their innervation to the MB horizontal lobes mediate either aversive or appetitive learning, and that subsets of PPL1 neurons can convey an aversive signal. Striking examples are shown by Hige et al. (2015) , who demonstrate that optogenetic stimulation of DA neurons innervating particular MB subdomains, leads to long-term depression of MB output neurons (MBONs) only if the DA-neurons are innervating the same MB subdomain. The implication of these studies is that DA released to specific regions of the MB horizontal lobes does not diffuse to adjacent domains. Here, we show this directly using our improved methodology for DA IR. Although the Split-Gal4 expression system is highly specific, we found some off-target neurons expressing UAS-GFP that do not overlap with TH IR and do not show DA IR in rescued brains (Fig. 5) . We suspect that these ectopic neurons could result from extremely low-level expression of each driver in these neurons, amplified by the high sensitivity of split-GAL4 followed by GFP detection.
We suspect that a nervous system developing in the absence of DA may develop compensatory mechanisms, and potentially altered neuronal processes, such that the DA-deficient brain may not be perfectly comparable with a wild-type brain architecture, but we have so far not detected any such abnormalities. Our pharmacological rescue with L-DOPA/carbiodopa combination may allow to generate a conditional model with DA synthesized from L-DOPA supplemented in a food present throughout the development, and DA-deficiency generated later in life by withdrawal from drugs.
Death of DA-neurons in the substantia nigra pars compacta is a major hallmark of PD, directly responsible for the locomotor symptoms. Currently, Parkinson's therapies are mostly limited to alleviating symptoms by DA replacement. It has been known for decades that up to 80% of substantia nigra DA neurons degenerate in a human brain prior to expression of the locomotor symptoms of PD (Hirsch et al. 1988; Hornykiewicz 1966) , although more recent studies suggest that only ∼30% of substantia nigra DA neurons and around 50-60% of their axon terminals have been lost when motor signs first appear (Cheng et al. 2010) . Compensatory signaling mechanisms likely play roles in maintaining functions of the nervous system during this period, and a viable brain DA-deficient model that allows sophisticated genetic manipulations will be a valuable research tool in elucidating these mechanisms.
Materials and methods
Generation of the 20 kb DTH FS+/− BAC construct
We generated a genetically recombineered BAC containing the DTH FS+/− (Riemensperger et al. 2011) , starting with the BAC plasmid CH322-134 F22 (Venken et al. 2006 (Venken et al. , 2009 , containing the wild-type DTH embedded within a 20 kb segment of genomic DNA (3L: 6 701 493 to 6 721 400), obtained from P[acman] Resources (Venken et al. 2006 (Venken et al. , 2009 . The DTH FS+/− BAC was constructed by recombineering a 2471 bp DNA fragment (synthesized by GeneScript, Piscataway, NJ, USA) containing portions of DTH exons 4 and 5 containing the DTH FS+/− mutations (Riemensperger et al. 2011) , and the neomycin (Neo) resistance marker flanked by loxP sites located within DTH intron 4 (Fig. S1) , with a 7 kb DTH FS+/− sequence in a pUAST vector, generating the plasmid pUAST DTH FS+/− Neo. Next, the 8.8 kb DTH FS+/− Neo fragment from pUAST DTH FS+/− Neo was recombineered with the wild-type DTH BAC CH322-134F22 to generate DTH FS+/− Neo BAC. The neomycin resistance cassette was then excised by Cre recombinase, leaving one loxP site in the intron between exons 4 and 5. The site of the intronic loxP insertion was chosen to avoid any conserved sequences when comparing the intronic region with the comparable sequences of other Drosophilids. The 20 kb DTH FS+/− BAC construct was validated by restriction digestion, Sanger sequencing and 454 sequencing. It was then site-specifically integrated into attP2 site on the third chromosome (Bischof et al. 2007) by Rainbow Transgenic Flies (Camarillo, CA, USA). The recombineering host strain was SW106 Escherichia coli, NCI-Frederick (Frederick, MD, USA) (Warming et al. 2005) 
Generation of the UAS-DTH1m construct
We generated UAS-DTH1m, an intronless DTH1 (neuronal isoform) cDNA with minimal 5 ′ and 3 ′ untranslated regions. This was accomplished by polymerase chain reaction (PCR) amplification of genomic DNA isolated from a transgenic fly containing UAS-DTH1.C. This is an intronless DTH1, but with extensive 5 ′ and 3 ′ UTRs. Primers were designed (see below) that amplified this sequence as a 1539 bp DTH1m sequence, with 12 bp 5 ′ UTR and no 3 ′ UTR. This fragment was cloned into EcoRI and XbaI restriction sites in a pUAST plasmid using the homologous recombination reagent, In-Fusion HD (Clontech, Mountain View, CA USA). The following primers were used for PCR amplification, vector homology regions underlined and initiating ATG and the termination codons in boldface:
DTHcDNAForEcoRI:
The construct was validated by Sanger sequencing and site-specifically integrated into the second chromosome attP40 site (Bischof et al. 2007) by Genetic Services (Sudbury, MA, USA).
High performance liquid chromatography
The HPLC with electrochemical detection (Decade, Antec Leyden B.V., Zoeterwoude, The Netherlands) was performed as per Hardie and Hirsh (2006) , using a mobile phase consisting of 50 mM citrate/acetate, pH 4.5, 1 mM decyl sulfonic acid, 0.1 mM Ethylenediaminetetraacetic acid (EDTA) and 7% acetonitrile modifying agent.
Quantitative polymerase chain reaction (qPCR)
The RNA was isolated from 10 brains per genotype using RNeasy Mini Kit (QIAGEN, Valencia, CA, USA). Reverse transcription was carried out using SuperScript ® VILO™ Master Mix (Invitrogen, Waltham, MA, USA) and qPCR reactions were run on an Applied Biosystems ® 7500 Fast Real-Time PCR machine. Expression was quantitated using a relative ΔΔCt method with internal control primers specific for Ef1 using 7500 Software v2.3 (Applied Biosystems, Foster City, CA, USA). Primers specific for the DTH transcript are isoform specific, detecting only the neural DTH1 isoform. The DTH CNS For primer is specific for the second DTH exon whereas DTH CNS Rev is complementary to the second to fifth exon-exon junction. EF1 For primer also spans an exon-exon junction. 
Immunohistochemistry
DTH immunohistochemistry
Adult brains were dissected in ice-cold Phosphate-buffered saline (PBS), fixed for 35 min in 4% paraformaldehyde at room temperature, and processed by standard procedures at room temperature (Vinayak et al. 2013) . The DTH was detected using a rabbit polyclonal anti-TH, diluted 1:40 (AB152, Millipore/Chemicon, Temecula, CA, USA). Budnik & White 1988) Solutions and reagents. Fix: 1.25% glutaraldehyde (Sigma G5882, Lot #SLBG1666V, Sigma-Aldrich Corp. St. Louis, MO, USA), 1% Na metabisulfite in PBS; PBS Metabisulfite (PM): PBS + 1% Na 2 S 2 O 5 ; NaBH4: 1% NaBH 4 in PBS; PM BSA Triton (PMBT): 5 ml PM + 5 mg bovine serum albumin (BSA) + 15 μl Triton X-100; Antibody: mouse monoclonal anti-DA diluted 1:40 (MAB5300 Millipore/Chemicon, Lot #2580700). The 25% glutaraldehyde stock solution, supplied under nitrogen gas, was divided into 20 μl aliquots in an anaerobic glove box and stored anaerobically at −20 ∘ C until use.
DA immunohistochemistry (adapted from
Procedure. Adult brains were dissected in ice-cold PBS and processed with all subsequent steps at 4 ∘ C unless noted. Fixation in 1.25% glutaraldehyde was for 3-4 h, followed by 3 × 20 min washes in PM and reduction for 40 min (22 ∘ C) in freshly prepared 1% NaBH 4. Brains were then washed 2 × 20 min in PM, 20 min in PMBT, and then overnight with PMBT containing 1% goat serum. This solution was replaced with primary antibody solution and incubated for 24 h, then washed 3 × 20 min in PBT (22 ∘ C). Incubation in secondary antibody solution was for 24 h, followed by 2 × 20 min washes in PBT. This solution was replaced with fresh PBT for an overnight wash, rinsed in 2 × 5 min in PBS and mounted in 60% 2,2-thiodiethanol (Costantini et al. 2015) . Confocal imaging was performed on a Leica SP5 X WLL Multispectral confocal microscope in the Keck Imaging Facility (University of Virginia). Images within individual figures were captured and processed with identical sensitivity/gain/contrast settings.
Flies and locomotor activity analysis
Male adult flies of indicated genotypes were 3-5 days post eclosion at initiation of behavioral analyses. Flies were raised on 12:12 LD light schedule at 25 ∘ C, 60% relative humidity. Fly locomotor activity was monitored in Trikinetics activity monitors (Waltham, MA, USA) for 5 days at 12:12 light:dark cycle, with 2 W/cm 2 intensity green LED light, at 22 ∘ C, 60% relative humidity. Sixteen to 32 male flies were used per condition, and activity monitor tubes contained a plug of fly food at one end. Data were analyzed using ClockLab 2.72 software (Coulbourne Instruments, Whitehall, PA, USA) and Microsoft Excel.
Drug feeding
The 3-IY (I8250, Sigma) and L-DOPA (D9628, Sigma) were mixed directly into melted fly food at final concentrations of 1.25 and 1 mg/ml, respectively. S-(−)-Carbidopa (C1335, Sigma) was dissolved in 1 ml of water at the 10× final concentration and mixed with 9 ml of melted fly food. The Trikinetics activity monitor tubes were loaded with a plug of food at one end, with drug feeding throughout the course of the experiment.
Statistical analyses
All statistical comparisons were performed using analysis of variance (ANOVA), with post hoc corrections for multiple comparisons using a Bonferroni correction. Sample numbers are given in relevant figure legends.
Supporting Information
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